ORGO
Income statement / Annual
Last year (2024), Organogenesis Holdings Inc.'s total revenue was $482.04 M,
an increase of 11.29% from the previous year.
In 2024, Organogenesis Holdings Inc.'s net income was $861.00 K.
See Organogenesis Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$482.04 M |
$433.14 M |
$450.89 M |
$467.36 M |
$338.30 M |
$260.98 M |
$193.45 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$115.74 M
|
$106.48 M
|
$105.02 M
|
$114.20 M
|
$87.32 M
|
$75.95 M
|
$68.81 M
|
$4.59 M
|
$208.70 K
|
| Gross Profit |
$366.30 M
|
$326.66 M
|
$345.87 M
|
$353.16 M
|
$250.98 M
|
$185.03 M
|
$124.64 M
|
-$4.59 M
|
-$208.70 K
|
| Gross Profit Ratio |
0.76
|
0.75
|
0.77
|
0.76
|
0.74
|
0.71
|
0.64
|
0
|
0
|
| Research and Development Expenses |
$50.27 M
|
$44.38 M
|
$39.76 M
|
$30.74 M
|
$20.09 M
|
$14.80 M
|
$10.74 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$264.53 M
|
$279.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$5.23 M
|
$4.81 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$294.51 M
|
$269.75 M
|
$283.81 M
|
$250.20 M
|
$204.19 M
|
$200.09 M
|
$161.96 M
|
$4.59 M
|
$208.70 K
|
| Other Expenses |
$22.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$162.00 K
|
$0.00
|
$208.70 K
|
| Operating Expenses |
$367.59 M
|
$314.13 M
|
$323.57 M
|
$280.94 M
|
$224.28 M
|
$214.89 M
|
$172.70 M
|
$4.59 M
|
$208.70 K
|
| Cost And Expenses |
$483.33 M
|
$420.62 M
|
$428.59 M
|
$395.14 M
|
$311.60 M
|
$290.84 M
|
$241.51 M
|
$4.59 M
|
$208.70 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$64.00 K
|
$0.00
|
$153.00 K
|
| Interest Expense |
$1.54 M
|
$2.19 M
|
$2.01 M
|
$7.24 M
|
$11.28 M
|
$9.00 M
|
$10.85 M
|
$8.01 M
|
$5.63 M
|
| Depreciation & Amortization |
$17.03 M
|
$23.45 M
|
$18.03 M
|
$16.68 M
|
$8.18 M
|
$9.83 M
|
$6.98 M
|
$5.63 M
|
-$417.40 K
|
| EBITDA |
$15.76 M |
$36.03 M |
$40.32 M |
$87.00 M |
$37.23 M |
-$19.74 M |
-$46.92 M |
-$2.09 M |
-$1.76 M |
| EBITDA Ratio |
0.03
|
0.08
|
0.09
|
0.19
|
0.11
|
-0.08
|
-0.24
|
0
|
0
|
| Operating Income Ratio |
-0
|
0.03
|
0.05
|
0.15
|
0.08
|
-0.11
|
-0.27
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.52 M
|
-$2.13 M
|
-$2.02 M
|
-$9.13 M
|
-$8.94 M
|
-$8.71 M
|
-$13.19 M
|
$3.40 M
|
$8.57 M
|
| Income Before Tax |
-$2.81 M
|
$10.39 M
|
$20.28 M
|
$63.09 M
|
$17.76 M
|
-$38.56 M
|
-$64.75 M
|
-$2.09 M
|
-$208.70 K
|
| Income Before Tax Ratio |
-0.01
|
0.02
|
0.04
|
0.13
|
0.05
|
-0.15
|
-0.33
|
0
|
0
|
| Income Tax Expense |
-$3.67 M
|
$5.45 M
|
$4.75 M
|
-$31.12 M
|
$530.00 K
|
$150.00 K
|
$84.00 K
|
-$52.52 K
|
-$440.21 K
|
| Net Income |
$861.00 K
|
$4.95 M
|
$15.53 M
|
$94.20 M
|
$17.23 M
|
-$38.71 M
|
-$64.83 M
|
-$2.09 M
|
-$208.70 K
|
| Net Income Ratio |
0
|
0.01
|
0.03
|
0.2
|
0.05
|
-0.15
|
-0.34
|
0
|
0
|
| EPS |
0.0065 |
0.0377 |
0.12 |
0.73 |
0.16 |
-0.44 |
-0.94 |
-0.0328 |
-0.0243 |
| EPS Diluted |
0.0065 |
0.0373 |
0.12 |
0.7 |
0.15 |
-0.44 |
-0.94 |
-0.0328 |
-0.0243 |
| Weighted Average Shares Out |
$131.67 M
|
$131.23 M
|
$130.07 M
|
$128.33 M
|
$107.74 M
|
$92.84 M
|
$68.97 M
|
$63.88 M
|
$8.58 M
|
| Weighted Average Shares Out Diluted |
$131.67 M
|
$132.75 M
|
$132.38 M
|
$133.66 M
|
$111.36 M
|
$92.84 M
|
$69.32 M
|
$63.88 M
|
$8.58 M
|
| Link |
|
|
|
|
|
|
|
|
|
